Connect with us at
2025 Alzheimer’s & Parkinson’s Diseases Conference
April 1–5 | Vienna, Austria
Advancing neurodegeneration research
with multi-platform proteomics
We’re excited to be at AD/PD 2025, showcasing how our cutting-edge proteomic technology is transforming neurodegeneration research. Visit us at Booth 81 to discover how our solutions are helping researchers identify novel biomarkers and drug targets for Alzheimer’s disease, Parkinson’s disease, ALS, frontotemporal dementia (FTD) and aging-related diseases.
Don’t miss these presentations featuring our technology
Our customers are leveraging multi-platform proteomics to drive groundbreaking discoveries in neurodegeneration.
Be sure to attend these insightful sessions:
Large-Scale CSF and Plasma Proteomics Reveal Dysregulation of Immune System, Synaptic Impairment, and Nuclear Envelope-Related Pathways in Neurodegeneration
Date: Tuesday, April 1 | Time: 9:00–9:15 am
Speaker: Muhammad Ali (US)
Session: AD Mechanisms and Molecular Systems (ID 576)
Location: Hall B
Multi-Platform Proteomics Unveils Global and Sex-Specific Plasma Markers for Predicting Cognitive Outcomes in Individuals at Risk of Alzheimer’s Disease
Date: Thursday, April 3 | Time: 9:55–10:10 am
Speaker: Federica Anastasi (Spain)
Session: Sex Similarities and Differences in Biomarkers & Pathophysiology (ID 56)
Location: Hall F2
The Global Neurodegeneration Proteomics Consortium – Biomarker and Drug Target Discovery Across ~40,000 Biosamples for AD, PD, ALS, FTD, and Aging
Date: Thursday, April 3 | Time: 5:35–5:50 pm
Speaker: Farhad Imam (US)
Session: Cell, Molecular and Systems Biology: Metabolomics, Transcriptomics, Lipidomics, Proteomics (ID 59)
Location: Hall F2
Plasma Proteomic Profiling of AD, PD and FTD in a Large Sample from the Global Neurodegeneration Proteomics Consortium (GNPC)
Date: Saturday, April 5 | Time: 8:40–8:55 am
Speaker: Betty Tijms (Netherlands)
Session: Fluid Biomarkers and Imaging in AD, PD, LBD, PSP and Small-Vessel Disease (ID 577)
Location: Hall F1
TDP-43-Regulated RNA Mis-Splicing is a Feature of High-Stage Chronic Traumatic Encephalopathy
Date: Saturday, April 5 | Time: 9:10–9:25 am
Speaker: Thor Stein (US)
Session: Mechanisms (TDP-43, C9ORF72, TMEM106B) and Clinical Trials in FTD, ALS and Neurodegeneration 02 (ID 101)
Location: Hall F2
Visit Booth 81 to learn more
Come explore how our advanced proteomic solutions are driving discoveries in neurodegeneration research. Whether you’re interested in cutting-edge biomarker discovery, multi-platform proteomic applications or collaborative research opportunities, we’re here to discuss how we can support your work.